| Gemtuzumab Ozogamicin studied in …STUDIED_INderived89 of 89show fewer |
|---|
| → studied in | NCT06917911Phase 2 · recruiting Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · 89 trials list this drug (17 active) | — | — | Core Binding Factor Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564390Phase 2 · recruiting MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · 89 trials list this drug (17 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801489Phase 2 · recruiting Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · 89 trials list this drug (17 active) | — | — | De Novo Myelodysplastic Syndrome,Myelodysplastic Syndrome with Excess Blasts,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04293562Phase 3 · recruiting A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05955261Phase 2 · recruiting A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05599360Phase 2 · active not recruiting Vyxeos for Induction of Low- or Intermediate-risk. · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05183035Phase 3 · recruiting Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03737955Phase 2 · recruiting Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03672539Phase 2 · completed Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome · 89 trials list this drug (17 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03374332Phase 1/Phase 2 · completed Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00658814Phase 2 · active not recruiting Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02724163Phase 3 · active not recruiting International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03568994early Phase 1 · completed Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML) · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06448013Phase 1 · recruiting A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03589729Phase 2 · recruiting Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers · 89 trials list this drug (17 active) | — | — | Myeloid Sarcoma,Myeloproliferative Neoplasm,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01409161Phase 2 · recruiting Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia · 89 trials list this drug (17 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04915612Phase 1 · completed Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03900949Phase 1 · completed Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05558124Phase 1 · recruiting CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04849910Phase 1/Phase 2 · terminated Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS · 89 trials list this drug (17 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04070768Phase 1 · completed Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113 · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05662904Phase 1 · not yet recruiting Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04168502Phase 3 · recruiting Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04207190Phase 1 · completed Talazoparib and Gemtuzumab Ozogamicin for the Treatment of CD33 Positive Relapsed or Refractory Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04793919Phase 2 · recruiting Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia · 89 trials list this drug (17 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02473146Phase 2/Phase 3 · completed Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4 · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03904251Phase 1 · terminated CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02117297Phase 2 · completed SCT Plus Immune Therapy in Average Risk AML/MDS · 89 trials list this drug (17 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02221310Phase 2 · completed Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS · 89 trials list this drug (17 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03390296Phase 1/Phase 2 · completed OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03531918Phase 1/Phase 2 · completed Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005962Phase 2 · completed Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049517Phase 3 · completed Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04173585Phase 2 · completed TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With Bortezomib · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878927Phase 1 · terminated CPX-351+GO in Subjects 55 Years Old, or Older, With AML · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00893399Phase 3 · completed Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Mutation · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00551460Phase 2 · completed S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04093505Phase 3 · terminated Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia) · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04326439Phase 2 · terminated AflacLL1901 (CHOA-AML) · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03727750Phase 4 · completed Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML · 89 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04337138completed A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01020539Phase 1 · completed Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia · 89 trials list this drug (17 active) | — | — | Juvenile Myelomonocytic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00372593Phase 3 · completed Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01698879Phase 2 · completed Prospective Study of Mylotarg and G-CSF in Acute Myeloid Leukemia Treatment · 89 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00895934Phase 1/Phase 2 · completed Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML · 89 trials list this drug (17 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00413166Phase 2 · completed All-trans Retinoic Acid, and Arsenic +/- Idarubicin · 89 trials list this drug (17 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00766116Phase 1/Phase 2 · completed Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML) · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038805Phase 2/Phase 3 · terminated Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS) · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01548911Phase 2 · withdrawn Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Adult Acute Myeloid Leukemia,Acute Myeloid Leukemia with del(5q),Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869803approved for marketing Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia · 89 trials list this drug (17 active) | — | — | Adult Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia,Acute Myeloid Leukemia with del(5q)+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03287128unknown Retrospective Analysis of the Outcome of Patients With Relapsed/Refractory Acute Myeloid Leukemia Included in a Patient Named Program of Gemtuzumab Ozogamicin/Mylotarg® · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00673153Phase 2 · terminated Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00121303Phase 3 · completed Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes · 89 trials list this drug (17 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006265Phase 2 · completed Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00476541Phase 3 · completed NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00660036Phase 1 · terminated Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00577694Phase 1 · terminated Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085709Phase 3 · completed S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274781Phase 2 · completed Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes · 89 trials list this drug (17 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00669890Phase 1 · terminated Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML · 89 trials list this drug (17 active) | — | — | Juvenile Myelomonocytic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049179Phase 2 · completed S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00798213Phase 2 · terminated SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED) · 89 trials list this drug (17 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02182596Phase 1/Phase 2 · completed DNR and AraC Combined to Fractionated Mylotarg® in Patients With First Relapse of AML · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028899Phase 1 · completed Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes · 89 trials list this drug (17 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070174Phase 2 · completed Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017589Phase 2 · completed Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00882102Phase 2 · completed Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS) · 89 trials list this drug (17 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454480Phase 2/Phase 3 · completed Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · 89 trials list this drug (17 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01041040Phase 4 · completed LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML) · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00195000Phase 2 · completed Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS · 89 trials list this drug (17 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00968071Phase 2 · completed Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome · 89 trials list this drug (17 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00037596Phase 2 · completed Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052299Phase 3 · completed Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003131Phase 2 · completed CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003673Phase 2 · completed CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038831Phase 1/Phase 2 · completed Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS · 89 trials list this drug (17 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091234Phase 2/Phase 3 · unknown Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006122Phase 2 · completed Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077116Phase 2 · completed Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome · 89 trials list this drug (17 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089050Phase 2 · completed Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00143975Phase 2 · completed Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM) · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008151Phase 2 · completed Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome · 89 trials list this drug (17 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00037583Phase 2 · completed Study Evaluating the Safety and Efficacy of Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00962767Phase 3 · completed Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00304447Phase 4 · completed Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia · 89 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00233909Phase 1/Phase 2 · completed A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia · 89 trials list this drug (17 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00460447Phase 1/Phase 2 · unknown Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00161668completed Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00044733Phase 2 · completed Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant · 89 trials list this drug (17 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |